ArticleGigaScience2026
MPLID (Membrane Protein-Lipid Interaction Database): A Large-Scale Experimental Resource of Residue-Level Protein-Lipid Contacts.
Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Membrane proteins constitute approximately 20-30% of all proteomes and represent over 60% of current drug targets. Although protein-lipid interactions play important structural and regulatory roles in membrane-associated proteins, most existing structural resources focus on identifying whether a residue lies within a membrane region, typically inferred from computational hydrophobicity-based positioning algorithms. This approach does not directly address a distinct biological question: which residues at the protein surface make direct physical contact with lipid molecules? Answering this question from experimental data is critical for understanding lipid-mediated allostery, designing lipid-mimetic therapeutics, and training accurate machine learning models for lipid-binding-site prediction. We present MPLID (Membrane Protein-Lipid Interaction Database), a curated residue-level dataset comprising 4,704 membrane proteins representing 813 sequence clusters at 30% identity, 8,055,325 residues, and 80,439 structurally observed lipid-contact annotations (1.00% observed positive rate). Labels are derived exclusively from experimentally resolved lipid molecules in experimentally determined Protein Data Bank structures using a 4.0 Å all-atom heavy-atom distance cutoff. Because many native lipid interactions are lost or remain unresolved during purification and structure determination, this observed rate represents a lower bound, and the non-contact class inevitably contains false negatives. The dataset uses a curated list of 117 candidate lipid identifiers across ten functional categories, including 90 PDB-derived ligand codes audited against the RCSB Chemical Component Dictionary and 27 CHARMM-style lipid identifiers encountered in cryo-EM depositions. These identifiers span phospholipids, cardiolipin, sphingolipids, sterols, fatty acids, glycerolipids, detergent mimetics, lipid A components, and CHARMM simulation nomenclature. To minimize data leakage, proteins are clustered at 30% sequence identity using MMseqs2, yielding 813 clusters partitioned into training (2,578), validation (1,051), and test (1,075) splits. Amino acid composition analysis reveals biologically consistent enrichment at lipid-contact sites: tryptophan (1.88×), arginine (1.44×), glycine (1.36×), lysine (1.33×), and phenylalanine (1.23×) are enriched, whereas proline (0.51×), isoleucine (0.57×), and aspartate (0.59×) are depleted. MPLID addresses a distinct biological question from existing resources such as OPM, MemBlob, and BioDolphin/PLIP by identifying residues that directly contact experimentally resolved lipid molecules rather than residues positioned within computationally defined membrane boundaries. With 4,704 proteins and more than 8 million annotated residues, MPLID provides the scale needed for training deep-learning models for lipid-contact prediction, with applications in structure-guided drug design and membrane-protein engineering. The dataset adheres to FAIR principles and is freely available under a CC0 public-domain dedication. Structurally resolved contacts represent only a subset of biological protein-lipid interactions, and MPLID is intended as an experimentally grounded resource rather than a complete catalogue of lipid-binding sites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.